Tamarra James-Todd, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phthalic Acids | 25 | 2023 | 436 | 6.320 |
Why?
|
| Environmental Pollutants | 29 | 2023 | 1179 | 6.250 |
Why?
|
| Endocrine Disruptors | 10 | 2023 | 237 | 4.630 |
Why?
|
| Hair Preparations | 7 | 2021 | 32 | 3.340 |
Why?
|
| Diabetes, Gestational | 14 | 2022 | 1184 | 2.960 |
Why?
|
| Cosmetics | 7 | 2023 | 97 | 2.890 |
Why?
|
| Fluorocarbons | 7 | 2023 | 452 | 2.500 |
Why?
|
| Maternal Exposure | 14 | 2023 | 961 | 1.960 |
Why?
|
| Environmental Exposure | 17 | 2023 | 4234 | 1.810 |
Why?
|
| Pregnancy in Diabetics | 6 | 2021 | 179 | 1.810 |
Why?
|
| Pregnancy | 65 | 2023 | 29144 | 1.780 |
Why?
|
| Blood Glucose | 18 | 2022 | 6256 | 1.750 |
Why?
|
| Premature Birth | 10 | 2023 | 1721 | 1.730 |
Why?
|
| Glucose Intolerance | 4 | 2022 | 577 | 1.690 |
Why?
|
| Pregnancy Trimester, First | 10 | 2022 | 853 | 1.650 |
Why?
|
| Pregnancy Trimester, Second | 9 | 2021 | 732 | 1.480 |
Why?
|
| Birth Weight | 15 | 2023 | 2069 | 1.440 |
Why?
|
| Diethylhexyl Phthalate | 4 | 2022 | 81 | 1.340 |
Why?
|
| Pregnancy Complications | 8 | 2020 | 2861 | 1.140 |
Why?
|
| Menarche | 3 | 2018 | 516 | 1.130 |
Why?
|
| Postpartum Period | 5 | 2020 | 1086 | 1.090 |
Why?
|
| Caprylates | 3 | 2020 | 111 | 1.010 |
Why?
|
| Alkanesulfonic Acids | 3 | 2022 | 180 | 0.960 |
Why?
|
| Body Mass Index | 15 | 2020 | 12720 | 0.940 |
Why?
|
| Hyperglycemia | 3 | 2019 | 1373 | 0.900 |
Why?
|
| Phenols | 4 | 2022 | 497 | 0.890 |
Why?
|
| Hair | 2 | 2023 | 483 | 0.860 |
Why?
|
| Oils | 1 | 2021 | 63 | 0.790 |
Why?
|
| Pregnancy Outcome | 6 | 2022 | 2795 | 0.780 |
Why?
|
| Benzophenones | 1 | 2020 | 57 | 0.730 |
Why?
|
| Diabetes Mellitus, Type 1 | 8 | 2022 | 3336 | 0.720 |
Why?
|
| Climate | 1 | 2020 | 147 | 0.710 |
Why?
|
| Boston | 11 | 2023 | 9313 | 0.700 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2022 | 489 | 0.660 |
Why?
|
| Fertility Agents | 1 | 2018 | 11 | 0.660 |
Why?
|
| Pregnancy Trimesters | 2 | 2017 | 192 | 0.640 |
Why?
|
| Fertility | 1 | 2023 | 781 | 0.640 |
Why?
|
| Trace Elements | 1 | 2019 | 198 | 0.630 |
Why?
|
| Benzhydryl Compounds | 3 | 2022 | 845 | 0.630 |
Why?
|
| Female | 91 | 2023 | 380194 | 0.630 |
Why?
|
| Cadmium | 1 | 2018 | 212 | 0.600 |
Why?
|
| Prenatal Exposure Delayed Effects | 5 | 2021 | 2408 | 0.580 |
Why?
|
| Copper | 1 | 2019 | 366 | 0.580 |
Why?
|
| Bayes Theorem | 9 | 2022 | 2309 | 0.570 |
Why?
|
| Fathers | 1 | 2019 | 358 | 0.570 |
Why?
|
| Health Status Disparities | 3 | 2022 | 1797 | 0.550 |
Why?
|
| Flame Retardants | 3 | 2021 | 87 | 0.550 |
Why?
|
| Infertility | 2 | 2020 | 655 | 0.530 |
Why?
|
| Obesity | 8 | 2023 | 12745 | 0.530 |
Why?
|
| Halogenated Diphenyl Ethers | 5 | 2022 | 77 | 0.530 |
Why?
|
| Emigrants and Immigrants | 2 | 2022 | 522 | 0.520 |
Why?
|
| Nutrition Surveys | 8 | 2022 | 1660 | 0.500 |
Why?
|
| Pre-Eclampsia | 2 | 2022 | 1200 | 0.500 |
Why?
|
| Adult | 52 | 2022 | 214055 | 0.470 |
Why?
|
| Infant, Newborn | 20 | 2023 | 25625 | 0.460 |
Why?
|
| Diabetes Mellitus, Type 2 | 9 | 2020 | 11725 | 0.450 |
Why?
|
| Humans | 99 | 2023 | 744343 | 0.450 |
Why?
|
| Gestational Age | 3 | 2021 | 3493 | 0.440 |
Why?
|
| Air Pollution | 2 | 2023 | 2286 | 0.430 |
Why?
|
| Fetus | 1 | 2020 | 1880 | 0.430 |
Why?
|
| Linear Models | 8 | 2022 | 5952 | 0.410 |
Why?
|
| Prospective Studies | 19 | 2023 | 53288 | 0.410 |
Why?
|
| Body Weight | 3 | 2017 | 4669 | 0.400 |
Why?
|
| Parabens | 3 | 2022 | 108 | 0.390 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2014 | 378 | 0.390 |
Why?
|
| Glucose | 2 | 2021 | 4397 | 0.390 |
Why?
|
| Hypoglycemia | 1 | 2017 | 861 | 0.370 |
Why?
|
| Young Adult | 22 | 2022 | 56430 | 0.350 |
Why?
|
| Air Pollution, Indoor | 3 | 2021 | 857 | 0.350 |
Why?
|
| Prenatal Care | 5 | 2021 | 1092 | 0.350 |
Why?
|
| Hot Flashes | 2 | 2022 | 317 | 0.340 |
Why?
|
| Depression | 4 | 2017 | 7766 | 0.340 |
Why?
|
| Menstruation | 1 | 2010 | 302 | 0.340 |
Why?
|
| Age Factors | 4 | 2020 | 18370 | 0.330 |
Why?
|
| Massachusetts | 5 | 2023 | 8663 | 0.320 |
Why?
|
| Overweight | 3 | 2020 | 2371 | 0.320 |
Why?
|
| Infant, Premature | 1 | 2017 | 2044 | 0.320 |
Why?
|
| New York City | 3 | 2018 | 710 | 0.310 |
Why?
|
| Cohort Studies | 14 | 2023 | 40561 | 0.310 |
Why?
|
| Pregnant Women | 4 | 2022 | 568 | 0.300 |
Why?
|
| Weight Gain | 2 | 2023 | 2292 | 0.300 |
Why?
|
| Exercise | 2 | 2020 | 5615 | 0.290 |
Why?
|
| Glucose Tolerance Test | 3 | 2020 | 1150 | 0.280 |
Why?
|
| Sigmoidoscopy | 1 | 2006 | 156 | 0.260 |
Why?
|
| Logistic Models | 10 | 2019 | 13408 | 0.250 |
Why?
|
| New York | 2 | 2021 | 886 | 0.250 |
Why?
|
| Fetal Development | 2 | 2022 | 767 | 0.250 |
Why?
|
| Odds Ratio | 6 | 2022 | 9849 | 0.240 |
Why?
|
| Maternal Age | 2 | 2019 | 802 | 0.230 |
Why?
|
| Soaps | 2 | 2023 | 28 | 0.230 |
Why?
|
| Perimenopause | 2 | 2022 | 139 | 0.230 |
Why?
|
| Environmental Monitoring | 5 | 2021 | 1414 | 0.230 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2022 | 26 | 0.210 |
Why?
|
| Longitudinal Studies | 6 | 2022 | 13989 | 0.210 |
Why?
|
| Phenanthrenes | 1 | 2022 | 63 | 0.210 |
Why?
|
| United States | 12 | 2022 | 69872 | 0.210 |
Why?
|
| Child | 15 | 2023 | 77709 | 0.210 |
Why?
|
| Menopause | 2 | 2021 | 1626 | 0.190 |
Why?
|
| Women's Health | 3 | 2022 | 2034 | 0.190 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2020 | 571 | 0.190 |
Why?
|
| Cross-Sectional Studies | 9 | 2022 | 25043 | 0.180 |
Why?
|
| Estrogens | 2 | 2021 | 1566 | 0.180 |
Why?
|
| Food Contamination | 1 | 2021 | 188 | 0.180 |
Why?
|
| Multivariate Analysis | 4 | 2019 | 12245 | 0.180 |
Why?
|
| Middle Aged | 18 | 2021 | 213383 | 0.180 |
Why?
|
| Molybdenum | 1 | 2019 | 46 | 0.180 |
Why?
|
| Humidity | 1 | 2020 | 197 | 0.180 |
Why?
|
| North America | 1 | 2023 | 1249 | 0.180 |
Why?
|
| Acculturation | 1 | 2020 | 182 | 0.170 |
Why?
|
| Paternal Exposure | 1 | 2019 | 89 | 0.170 |
Why?
|
| Social Justice | 1 | 2023 | 456 | 0.170 |
Why?
|
| Pilot Projects | 4 | 2023 | 8324 | 0.160 |
Why?
|
| Commerce | 1 | 2023 | 592 | 0.160 |
Why?
|
| beta Carotene | 1 | 2019 | 527 | 0.160 |
Why?
|
| Analgesia, Obstetrical | 1 | 2019 | 177 | 0.160 |
Why?
|
| Adolescent | 15 | 2023 | 85781 | 0.150 |
Why?
|
| Cotinine | 1 | 2018 | 206 | 0.150 |
Why?
|
| Colonoscopy | 1 | 2006 | 1367 | 0.150 |
Why?
|
| Puerperal Disorders | 1 | 2020 | 275 | 0.150 |
Why?
|
| Risk Factors | 13 | 2019 | 72290 | 0.150 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2019 | 245 | 0.150 |
Why?
|
| Obstetric Labor Complications | 1 | 2019 | 238 | 0.150 |
Why?
|
| Insulin | 4 | 2022 | 6580 | 0.150 |
Why?
|
| Hypotension | 1 | 2023 | 884 | 0.150 |
Why?
|
| Parity | 1 | 2020 | 929 | 0.150 |
Why?
|
| Metals | 1 | 2021 | 719 | 0.140 |
Why?
|
| Selenium | 1 | 2019 | 405 | 0.140 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2019 | 456 | 0.140 |
Why?
|
| Analgesia, Epidural | 1 | 2019 | 327 | 0.140 |
Why?
|
| Environmental Health | 1 | 2018 | 278 | 0.140 |
Why?
|
| Age of Onset | 2 | 2014 | 3271 | 0.140 |
Why?
|
| Zinc | 1 | 2019 | 684 | 0.130 |
Why?
|
| Hypoglycemic Agents | 3 | 2022 | 2872 | 0.130 |
Why?
|
| Infant, Low Birth Weight | 2 | 2023 | 850 | 0.120 |
Why?
|
| Risk | 3 | 2018 | 9687 | 0.120 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2016 | 1572 | 0.120 |
Why?
|
| China | 1 | 2020 | 2248 | 0.120 |
Why?
|
| Analysis of Variance | 2 | 2016 | 6365 | 0.120 |
Why?
|
| Self Report | 4 | 2019 | 3558 | 0.120 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2021 | 1320 | 0.120 |
Why?
|
| Seasons | 1 | 2020 | 1493 | 0.120 |
Why?
|
| Triglycerides | 1 | 2022 | 2454 | 0.120 |
Why?
|
| Temperature | 1 | 2020 | 2206 | 0.120 |
Why?
|
| Interviews as Topic | 3 | 2012 | 2539 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 5751 | 0.120 |
Why?
|
| Sex Factors | 2 | 2020 | 10397 | 0.110 |
Why?
|
| Stillbirth | 1 | 2016 | 346 | 0.110 |
Why?
|
| Insulin Infusion Systems | 1 | 2014 | 212 | 0.110 |
Why?
|
| Mexican Americans | 1 | 2014 | 166 | 0.110 |
Why?
|
| Mothers | 1 | 2023 | 2165 | 0.110 |
Why?
|
| Particulate Matter | 2 | 2022 | 2530 | 0.110 |
Why?
|
| Cholesterol | 1 | 2022 | 2917 | 0.110 |
Why?
|
| Pregnancy Proteins | 1 | 2013 | 229 | 0.110 |
Why?
|
| Public Health | 2 | 2023 | 2603 | 0.110 |
Why?
|
| Male | 17 | 2023 | 350118 | 0.100 |
Why?
|
| Societies, Medical | 1 | 2014 | 3743 | 0.100 |
Why?
|
| Fever | 1 | 2019 | 1616 | 0.100 |
Why?
|
| Erythrocytes | 1 | 2021 | 2455 | 0.100 |
Why?
|
| Language | 1 | 2020 | 1471 | 0.100 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2017 | 780 | 0.100 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2013 | 440 | 0.100 |
Why?
|
| Social Class | 3 | 2019 | 1999 | 0.100 |
Why?
|
| Sulfonamides | 1 | 2020 | 1938 | 0.090 |
Why?
|
| Aged | 10 | 2019 | 163280 | 0.090 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 1889 | 0.090 |
Why?
|
| Adiposity | 1 | 2020 | 1807 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2013 | 552 | 0.090 |
Why?
|
| Aged, 80 and over | 6 | 2019 | 57776 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 39050 | 0.090 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2021 | 2026 | 0.090 |
Why?
|
| Spouse Abuse | 1 | 2010 | 178 | 0.090 |
Why?
|
| Fasting | 1 | 2015 | 1593 | 0.080 |
Why?
|
| Infant | 6 | 2022 | 35136 | 0.080 |
Why?
|
| Occupations | 1 | 2010 | 517 | 0.080 |
Why?
|
| Prejudice | 1 | 2012 | 570 | 0.080 |
Why?
|
| Child Abuse, Sexual | 1 | 2010 | 383 | 0.080 |
Why?
|
| Dust | 2 | 2021 | 482 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2018 | 6459 | 0.080 |
Why?
|
| Air Pollutants | 1 | 2021 | 2817 | 0.070 |
Why?
|
| Prevalence | 4 | 2018 | 15226 | 0.070 |
Why?
|
| Blood Glucose Self-Monitoring | 2 | 2022 | 434 | 0.070 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2010 | 260 | 0.070 |
Why?
|
| Models, Theoretical | 1 | 2018 | 3589 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2006 | 6773 | 0.070 |
Why?
|
| Gastric Bypass | 1 | 2014 | 812 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2019 | 6196 | 0.070 |
Why?
|
| Educational Status | 1 | 2013 | 2540 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2019 | 3864 | 0.070 |
Why?
|
| DNA Methylation | 1 | 2019 | 4286 | 0.070 |
Why?
|
| Statistics as Topic | 1 | 2012 | 2373 | 0.070 |
Why?
|
| Occult Blood | 1 | 2006 | 176 | 0.060 |
Why?
|
| Osteoarthritis | 1 | 2013 | 1036 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2010 | 2971 | 0.060 |
Why?
|
| Textbooks as Topic | 1 | 2004 | 19 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2019 | 7729 | 0.060 |
Why?
|
| Alkanesulfonates | 1 | 2023 | 15 | 0.060 |
Why?
|
| Obesity, Morbid | 1 | 2014 | 1213 | 0.060 |
Why?
|
| Incidence | 3 | 2018 | 20947 | 0.060 |
Why?
|
| Weight Loss | 1 | 2014 | 2622 | 0.060 |
Why?
|
| Diet | 1 | 2021 | 7939 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 19905 | 0.050 |
Why?
|
| Dicarboxylic Acids | 1 | 2022 | 69 | 0.050 |
Why?
|
| Urban Population | 1 | 2011 | 2021 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2020 | 77449 | 0.050 |
Why?
|
| Cardiovascular Diseases | 2 | 2018 | 15165 | 0.050 |
Why?
|
| Child Abuse | 1 | 2010 | 1030 | 0.050 |
Why?
|
| Plastics | 1 | 2022 | 123 | 0.050 |
Why?
|
| Naphthalenes | 1 | 2022 | 194 | 0.050 |
Why?
|
| Beta Particles | 1 | 2021 | 50 | 0.050 |
Why?
|
| Stress, Psychological | 2 | 2016 | 4245 | 0.050 |
Why?
|
| Smoking | 1 | 2018 | 8987 | 0.050 |
Why?
|
| Hypercholesterolemia | 2 | 2018 | 1151 | 0.050 |
Why?
|
| Maintenance | 1 | 2020 | 25 | 0.050 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2021 | 141 | 0.050 |
Why?
|
| Fluorenes | 1 | 2022 | 160 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2016 | 9146 | 0.050 |
Why?
|
| Epidemiology | 1 | 2004 | 287 | 0.050 |
Why?
|
| Body Fat Distribution | 1 | 2022 | 244 | 0.050 |
Why?
|
| Silicones | 1 | 2021 | 250 | 0.050 |
Why?
|
| Child, Preschool | 4 | 2023 | 41006 | 0.050 |
Why?
|
| Hydroxylation | 1 | 2019 | 141 | 0.040 |
Why?
|
| Esters | 1 | 2020 | 210 | 0.040 |
Why?
|
| Fetal Macrosomia | 1 | 2020 | 124 | 0.040 |
Why?
|
| Luciferases | 1 | 2021 | 733 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 2006 | 1405 | 0.040 |
Why?
|
| Breast | 1 | 2008 | 1969 | 0.040 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 4644 | 0.040 |
Why?
|
| Epidemiologic Methods | 1 | 2004 | 1364 | 0.040 |
Why?
|
| Mental Health | 1 | 2012 | 3019 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 2282 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2019 | 23338 | 0.040 |
Why?
|
| Gonads | 1 | 2016 | 109 | 0.040 |
Why?
|
| Culture | 1 | 2020 | 633 | 0.040 |
Why?
|
| Kuwait | 1 | 2016 | 86 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2021 | 871 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 940 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2018 | 1792 | 0.030 |
Why?
|
| Sex Characteristics | 2 | 2016 | 2585 | 0.030 |
Why?
|
| Leiomyoma | 1 | 2019 | 730 | 0.030 |
Why?
|
| Primary Prevention | 1 | 2021 | 1167 | 0.030 |
Why?
|
| Body Composition | 1 | 2023 | 2401 | 0.030 |
Why?
|
| Pituitary-Adrenal System | 1 | 2016 | 553 | 0.030 |
Why?
|
| Time Factors | 1 | 2015 | 40075 | 0.030 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2016 | 703 | 0.030 |
Why?
|
| Metabolomics | 1 | 2020 | 1484 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 20822 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2023 | 21746 | 0.020 |
Why?
|
| Ambulatory Care Facilities | 1 | 2017 | 933 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 12354 | 0.020 |
Why?
|
| Testosterone | 1 | 2021 | 2420 | 0.020 |
Why?
|
| Bone Density | 1 | 2023 | 3468 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2016 | 1403 | 0.020 |
Why?
|
| Fertilization in Vitro | 1 | 2017 | 1284 | 0.020 |
Why?
|
| Hypertension | 2 | 2018 | 8480 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 2012 | 7785 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2023 | 8554 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 1157 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 3647 | 0.020 |
Why?
|
| Recurrence | 1 | 2018 | 8340 | 0.020 |
Why?
|
| Research Design | 1 | 2020 | 5987 | 0.020 |
Why?
|
| Switzerland | 1 | 2004 | 255 | 0.010 |
Why?
|
| Comorbidity | 1 | 2016 | 10388 | 0.010 |
Why?
|
| Postmenopause | 1 | 2008 | 2461 | 0.010 |
Why?
|
| Mammography | 1 | 2008 | 2476 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2004 | 2740 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 15540 | 0.010 |
Why?
|
| Animals | 1 | 2020 | 168757 | 0.010 |
Why?
|